Moderna Inc (XKAZ:MRNA_KZ)
$ 94 0 (0%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 62/100

Moderna Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 02, 2020 / 02:00PM GMT
Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Good morning. My name is Ted Tenthoff. I'm a senior biotechnology analyst at Piper Sandler, and welcome to our Virtual Health Care Conference. Moderna is the leading developer of messenger RNA, or mRNA technology. The company has become a household name around the globe, thanks to their tireless efforts to develop and manufacture SARS-CoV-2 vaccine, mRNA-1273.

I'm pleased to introduce my good friend, CEO, Stéphane Bancel. Thanks for taking the time out of your very busy schedule to speak with us today. Congratulations on all the success this year.

StÃ;phane Bancel;Edward Andrew Tenthoff<
Moderna, Inc. - CEO & Director

© -

Thanks so much, Ted, for having us, and thank you for the kind word. It has been a long year. I've been really amazed and very proud of the team. It has taken a village to get this to a finish line or almost to a finish line. We have EUA filed on Monday and filing also to Europe. So thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot